Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pruritus, Rash, Staphylococcal infection, Vocal cord disorder
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (early May 2021, terrible itching all over body that is ongoing to this day and is intermittent/she does itchy and it happens on different parts of body), STAPHYLOCOCCAL INFECTION (finished sulfa that she had taken for a staph infection), VOCAL CORD DISORDER (some days she can not talk because she has growth on vocal cords), RASH (broke out from head to toe even in belly bottom on 3Apr2021) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 5Feb2021 Date of 2nd dose 18Mar2021) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 030L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE, LISINOPRIL DIHYDRATE (LISINOPRIL [LISINOPRIL DIHYDRATE]), OMEPRAZOLE, SIMVASTATIN, ZOLPIDEM, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), CALCIUM, MULTIVITAMIN [VITAMINS NOS], GARLIC [ALLIUM SATIVUM], VITAMIN C [ASCORBIC ACID], FLAXSEED OIL [LINUM USITATISSIMUM SEED OIL] and LACTOFERRIN for an unknown indication.On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 5Feb2021 Date of 2nd dose 18Mar2021). On 03-Apr-2021, the patient experienced RASH (broke out from head to toe even in belly bottom on 3Apr2021). In May 2021, the patient experienced PRURITUS (early May 2021, terrible itching all over body that is ongoing to this day and is intermittent/she does itchy and it happens on different parts of body). On an unknown date, the patient experienced STAPHYLOCOCCAL INFECTION (finished sulfa that she had taken for a staph infection) and VOCAL CORD DISORDER (some days she can not talk because she has growth on vocal cords). The patient was treated with HYDROXYZINE for Adverse event, at an unspecified dose and frequency; TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency; AMMONIUM LACTATE (AMLACTIN) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 18-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 5Feb2021 Date of 2nd dose 18Mar2021) had resolved. At the time of the report, PRURITUS (early May 2021, terrible itching all over body that is ongoing to this day and is intermittent/she does itchy and it happens on different parts of body), STAPHYLOCOCCAL INFECTION (finished sulfa that she had taken for a staph infection), VOCAL CORD DISORDER (some days she can not talk because she has growth on vocal cords) and RASH (broke out from head to toe even in belly bottom on 3Apr2021) had not resolved. The treatment medications included Sharma, Cerave used for adverse event indication and patient stated that she went to ER she had finished sulfa that she had taken for a staph infection. Patient went to ER where she was given medication to help the symptoms. The patient took Lisinopril as a concomitant and stated that she took 8x the amount and almost had a stroke.Patient stated that  she had followed up with dermatologist and family doctor who do not have a diagnosis they do not know what was it but just helped to treat symptoms. Patient stated that her family doctor does not recommend getting a booster dose based on her symptoms.Patient stated that  her family doctor does not recommend a booster dose based on the symptoms.